127 results
Page 2 of 7
6-K
EX-99.1
iuitd2lf39ye3vp7hbi
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.3
mygjtp1e3q1l7rrj4
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.2
5vsel35jn 7nrzo
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
dd2pfsus2i
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
8rgkhb
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.1
3uukr5 heepa
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
zqxb 732qcr
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
3xdwuhg
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.2
e40f6kjeg4afjip
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
7bky0jn n38w34q6072o
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
6-K
EX-99.2
p7yzso 4xycl4cpb2qh
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
69o eckedow3vhdab
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.2
af62jx7pbot0a i4xr8g
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
l6g2 zhuahufsqx2w
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
p8073lokd6705i
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
ns9zum4
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm